Psyomics appoints US digital health leader Raj Malik to Board to support next phase of growth

Psyomics appoints US digital health leader Raj Malik to Board

Dr Melinda Rees, CEO of Psyomics

The Psyomics team

Digital mental health company Psyomics has appointed experienced US healthcare executive Raj Malik to its Board.

LONDON, LONDON, UNITED KINGDOM, September 17, 2026 /EINPresswire.com/ -- Digital mental health company Psyomics has appointed experienced US healthcare executive Raj Malik to its Board as the business grows in the UK and focuses on international expansion.

Raj brings more than 30 years’ experience across digital health, technology, law and business leadership. He has built and scaled businesses in the US, the UK and internationally, supported major capital raises and acquisitions, and helped grow Rally Health from launch to $2 billion in revenue ahead of its acquisition by Optum.

His appointment comes as Psyomics enters a new stage of commercial growth. The company is expanding the use of its digital mental health platform and is preparing to launch its biomarker technology.

Raj will work with CEO Dr Melinda Rees, the senior leadership team and fellow Board members, providing strategic guidance on commercial growth, investor engagement and future international expansion, including opportunities in the US.

Dr Melinda Rees, CEO of Psyomics, said: “Raj has taken a digital health company from an early stage to $2 billion in ARR and to an exit and that is the exact trajectory we're building toward. Now we have someone in the room who can work with our team who's actually done that."

“He understands how to scale technology businesses, build strong teams and grow sustainably, and brings valuable experience of both the UK and US markets. His appointment strengthens the Board at an important point in our development and will help us make the most of the opportunities ahead.”

Raj began his career in law as an Assistant Attorney General before becoming an antitrust attorney at White & Case. This extensive regulatory background gives him direct insight into the regulatory and procurement environment in which NHS-facing companies operate.

Throughout his career, Raj has built, grown, scaled and sold companies, serving as CEO and in other senior leadership roles. This has included the sale of businesses to Optum, Google and General Atlantic. His international experience spans the US, UK, Europe, Brazil, Africa, India and Canada.

Raj is a National Association of Corporate Directors Certified Director and has been inducted into the Dealmakers Hall of Fame.

Raj said: “The mental health crisis is one of the biggest challenges we face globally, and it is also something that throughout my career I've seen up close with colleagues, friends and family.”

“Psyomics stood out because it has an incredibly talented mission oriented team that developed a biomarker capability that truly sets it apart from other digital mental health platforms I have evaluated. I’m looking forward to using my experience to help the team scale its work, demonstrate meaningful outcomes and ultimately improve more patients’ lives.”

Psyomics is developing an approach that combines digital mental health assessment with biomarker technology to support clinical decision-making and help people access appropriate care.

The company’s currently focused on expanding its growing UK customer base while demonstrating the clinical and operational impact of its technology. This continued UK growth is leading to dedicated plans to expand into international markets, with the US representing a significant opportunity.

Melinda added: “Raj’s decision to join Psyomics is a strong endorsement of what the team has built. His strategic insight, commercial experience and understanding of the US healthcare and investment landscape will be invaluable as we move into our next phase.”

For more information visit http://www.psyomics.com

Julia Winder
JPPR
+44 7737 864878
email us here